These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30044539)

  • 1. Cytomegalovirus Infection: Mouse Model.
    Brizić I; Lisnić B; Brune W; Hengel H; Jonjić S
    Curr Protoc Immunol; 2018 Aug; 122(1):e51. PubMed ID: 30044539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Models for Cytomegalovirus Infections in Newborns and Adults.
    Brizić I; Lisnić B; Krstanović F; Brune W; Hengel H; Jonjić S
    Curr Protoc; 2022 Sep; 2(9):e537. PubMed ID: 36083111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model for cytomegalovirus infection.
    Brune W; Hengel H; Koszinowski UH
    Curr Protoc Immunol; 2001 Aug; Chapter 19():Unit 19.7. PubMed ID: 18432758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolving the titer of murine cytomegalovirus by plaque assay using the M2-10B4 cell line and a low viscosity overlay.
    Zurbach KA; Moghbeli T; Snyder CM
    Virol J; 2014 Apr; 11():71. PubMed ID: 24742045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine Cytomegalovirus Spread Depends on the Infected Myeloid Cell Type.
    Farrell HE; Bruce K; Lawler C; Stevenson PG
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.
    Pollock JL; Virgin HW
    J Virol; 1995 Mar; 69(3):1762-8. PubMed ID: 7853515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV.
    Wang H; Yao Y; Huang C; Fu X; Chen Q; Zhang H; Chen J; Fang F; Xie Z; Chen Z
    BMC Infect Dis; 2014 Apr; 14():195. PubMed ID: 24720840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair of an Attenuated Low-Passage Murine Cytomegalovirus Bacterial Artificial Chromosome Identifies a Novel Spliced Gene Essential for Salivary Gland Tropism.
    Redwood AJ; Masters LL; Chan B; Leary S; Forbes C; Jonjić S; Juranić Lisnić V; Lisnić B; Smith LM
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3.
    Alston CI; Dix RD
    PLoS One; 2017; 12(2):e0171812. PubMed ID: 28182772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of murine cytomegalovirus salivary-gland infection by combined therapy with ganciclovir and thymic humoral factor gamma 2.
    Palmon A; Blagerman S; Tel-Or S; Pecht M; Trainin N; Burstein Y; Rager-Zisman B
    Antiviral Res; 1996 Dec; 33(1):55-64. PubMed ID: 8955853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A focused salivary gland infection with attenuated MCMV: an animal model with prevention of pathology associated with systemic MCMV infection.
    Pilgrim MJ; Kasman L; Grewal J; Bruorton ME; Werner P; London L; London SD
    Exp Mol Pathol; 2007 Jun; 82(3):269-79. PubMed ID: 17320076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model.
    Fritz NM; Stamminger T; Ramsperger-Gleixner M; Kuckhahn AV; Müller R; Weyand M; Heim C
    Transpl Immunol; 2021 Feb; 64():101359. PubMed ID: 33301898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine cytomegalovirus-Pseudomonas synergistic infections: comparison of virulent and attenuated virus.
    Kournikakis B; Babiuk LA
    Can J Microbiol; 1987 Oct; 33(10):923-7. PubMed ID: 2825950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR.
    Wheat RL; Clark PY; Brown MG
    J Virol Methods; 2003 Sep; 112(1-2):107-13. PubMed ID: 12951218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution.
    McWhorter AR; Smith LM; Masters LL; Chan B; Shellam GR; Redwood AJ
    PLoS Pathog; 2013 Jan; 9(1):e1003111. PubMed ID: 23300458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus causes a latent infection in undifferentiated cells and is activated by induction of cell differentiation.
    Dutko FJ; Oldstone MB
    J Exp Med; 1981 Nov; 154(5):1636-51. PubMed ID: 6271894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mouse Cytomegalovirus G Protein-Coupled Receptor Homolog, M33, Coordinates Key Features of
    Ma J; Bruce K; Davis-Poynter N; Stevenson PG; Farrell HE
    J Virol; 2022 Feb; 96(4):e0186721. PubMed ID: 34878888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.